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HDR brachytherapy in vivo source position verification using a 2D diode array: A
Monte Carlo study
Abstract

Purpose
This study aims to assess the accuracy of source position verification during high‐dose rate (HDR)
prostate brachytherapy using a novel, in‐house developed two‐dimensional (2D) diode array (the Magic
Plate), embedded exactly below the patient within a carbon fiber couch. The effect of tissue
inhomogeneities on source localization accuracy is examined.

Method
Monte Carlo (MC) simulations of 12 source positions from a HDR prostate brachytherapy treatment were
performed using the Geant4 toolkit. An Ir‐192 Flexisource (Isodose Control, Veenendaal, the Netherlands)
was simulated inside a voxelized patient geometry, and the dose deposited in each detector of the Magic
Plate evaluated. The dose deposited in each detector was then used to localize the source position using
a proprietary reconstruction algorithm.

Results
The accuracy of source position verification using the Magic Plate embedded in the patient couch was
found to be affected by the tissue inhomogeneities within the patient, with an average difference of 2.1 ±
0.8 mm (k = 1) between the Magic Plate predicted and known source positions. Recalculation of the
simulations with all voxels assigned a density of water improved this verification accuracy to within 1
mm.

Conclusion
Source position verification using the Magic Plate during a HDR prostate brachytherapy treatment was
examined using MC simulations. In a homogenous geometry (water), the Magic Plate was able to localize
the source to within 1 mm, however, the verification accuracy was negatively affected by inhomogeneities;
this can be corrected for by using density information obtained from CT, making the proposed tool
attractive for use as a real‐time in vivo quality assurance (QA) device in HDR brachytherapy for prostate
cancer.
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HDR brachytherapy in vivo source position veriﬁcation using
a 2D diode array: A Monte Carlo study
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1
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Abstract
Purpose: This study aims to assess the accuracy of source position veriﬁcation dur-

2

St George Hospital Cancer Care Centre,
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ing high-dose rate (HDR) prostate brachytherapy using a novel, in-house developed
two-dimensional (2D) diode array (the Magic Plate), embedded exactly below the
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patient within a carbon ﬁber couch. The effect of tissue inhomogeneities on source
localization accuracy is examined.
Method: Monte Carlo (MC) simulations of 12 source positions from a HDR prostate
brachytherapy treatment were performed using the Geant4 toolkit. An Ir-192 Flexisource (Isodose Control, Veenendaal, the Netherlands) was simulated inside a voxelized patient geometry, and the dose deposited in each detector of the Magic
Plate evaluated. The dose deposited in each detector was then used to localize the
source position using a proprietary reconstruction algorithm.
Results: The accuracy of source position veriﬁcation using the Magic Plate embedded in the patient couch was found to be affected by the tissue inhomogeneities
within the patient, with an average difference of 2.1  0.8 mm (k = 1) between the
Magic Plate predicted and known source positions. Recalculation of the simulations
with all voxels assigned a density of water improved this veriﬁcation accuracy to
within 1 mm.
Conclusion: Source position veriﬁcation using the Magic Plate during a HDR prostate brachytherapy treatment was examined using MC simulations. In a homogenous
geometry (water), the Magic Plate was able to localize the source to within 1 mm,
however, the veriﬁcation accuracy was negatively affected by inhomogeneities; this
can be corrected for by using density information obtained from CT, making the
proposed tool attractive for use as a real-time in vivo quality assurance (QA) device
in HDR brachytherapy for prostate cancer.
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1 | INTRODUCTION

the Centre for Medical Radiation Physics (CMRP), University of Wol-

When used in combination with external beam radiotherapy (EBRT)

HDR prostate brachytherapy treatment. Previous studies performed

in the form of a boost, high-dose rate (HDR) brachytherapy has been

with the MP in homogeneous phantom media and have reported

shown to be a safe and effective treatment modality for intermedi-

source localization accuracy of less than 1 mm16,20,21 and temporal

longong (UoW), Australia, for in vivo source position veriﬁcation of a

1,2

Despite recent technological

resolution of 1 ms,20 making it an ideal device for real-time source

developments in the ﬁeld of brachytherapy, such as image-guided

position veriﬁcation. It is hypothesized that the introduction of

ate- and high-risk prostate cancer.
3,4

brachytherapy,
applicator

5

6

treatment planning, electromagnetic tracking, and

development,7–9

poor

execution

of

HDR

prostate

heterogeneous media associated with the patient geometry may
compromise the accuracy of source localization using this device.

brachytherapy can still have a signiﬁcant effect on patient outcomes.

To assess the feasibility of source localization using the MP in

Furthermore, the incidences of errors that may occur in the practice

the presence of patient-related heterogeneities, MC simulations

of HDR prostate brachytherapy is relatively unknown, and limited

were performed using the Geant4 toolkit (v4.10.01).22,23 During the

options exist for independent routine monitoring of treatment deliv-

HDR prostate brachytherapy treatment simulations, the Flexisource

ery. There are a number of published documents by the International

Ir-192 source (Isodose Control, Veenendaal, the Netherlands) was

Commission on Radiological Protection (ICRP)10,11 as well as the

simulated inside a voxelized patient geometry, and the dose depos-

12

International Atomic Energy Association (IAEA)

describing errors

ited within the sensitive volume of each detector in the couch

that have occurred in HDR brachytherapy. Many of these errors are

embedded 11 9 11 diode array was evaluated. The simulated detec-

related to human miscalculations, and less often, due to machine or

tor dose was then used to determine the distance of all detectors in

computational malfunction. The likelihood of remote afterloader mal-

the array to each of the simulated source positions. Finally, the

function is generally considered extremely low; however, small devi-

source position was determined using an iterative procedure where

ations from the plan in source dwell position and time can result in

the source position is ﬁrst estimated, and then repeatedly reﬁned

signiﬁcant errors in the dose delivered to the patient.13

based upon the agreement of the predicted geometric distance from

The American Association of Physicists in Medicine (AAPM)
Radiation Therapy Task Group (TG) No. 5914 recommends that insti-

the source to the detectors against those determined by the detectors in the array.

tutions employ a quality assurance (QA) program that exploits redundancy and review the entire treatment planning and delivery process
to isolate any actions susceptible to errors. The report suggests that
incidence of these errors may be reduced by the introduction of pretreatment QA in the time between treatment planning and delivery.

2 | MATERIALS AND METHODS
2.A | Ir-192 Flexisource

Further to this, another AAPM Report from TG 5615 recommends

The geometric design of the Flexisource model was obtained from

that the source position, source dwell time, and transit time be

the study performed by Granero et al.24 and is shown in Fig. 1. A

quantiﬁed by the medical physicist on a regular basis. A combination

detailed description of the Flexisource model used in the simulations

of these regular and pretreatment QA checks, along with a well-

is included in Appendix I.

documented treatment planning and delivery protocol will go a long
way to ensuring safe and successful delivery of HDR brachytherapy
treatment plans. However, this type of QA program will not safe-

2.B | Magic Plate diode array

guard the HDR brachytherapy delivery from all types of errors. An

The MP is a 2D silicon diode array developed at the CMRP, UoW,

ideal system for HDR brachytherapy treatment veriﬁcation should be

Australia, originally as a tool for intensity modulated radiation ther-

able to provide real-time identiﬁcation of the dwell positions, mea-

apy (IMRT) QA.25,26 The MP has since been validated as a tool for

sure the dwell and transit times, and compare these parameters with

Ir-192 source position veriﬁcation with focus on pretreatment qual-

the prescribed treatment plan both before and during treatment.16

ity assurance.16,21

Real-time source identiﬁcation of dwell positions during HDR

The MP consists of an 11 9 11 array of epitaxial diodes

prostate brachytherapy treatments based on electronic portal imag-

mounted on a 0.6 mm Kapton substrate using the “drop-in” tech-

ing devices (EPIDs) have been performed previously.17–19 In one

nique. The structure of the MP is modeled in the Geant4 MC simula-

study, the authors retrospectively compared the planned vs mea-

tions in this study using the description by Wong, et al.25 and is

sured source positions using an EPID embedded into the couch for

shown in Figs. 2(a) and 2(b).

eight treatment fractions, and the mean linear distance between the
planned and measured dwell positions was found to be 1.8 mm
(range 0.7–3.9 mm).17 However, these EPID-based devices suffer

2.C | TG-43 simulations

from low frame rates and slow readout electronics, resulting in loss

Before using the Flexisource model in MC studies, the physics mod-

of data for short dwell times.18

eling within the prospective MC simulations was validated against

This study aims to investigate the feasibility of using a two-

benchmark data via TG-43 simulations. The AAPM TG43-U1

dimensional (2D) diode array, the “Magic Plate” (MP), developed at

report27 recommends that MC simulations used to obtain TG-43
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F I G . 1 . Schematic of Flexisource Ir-192
source24 modeled in this study. All
dimensions are in millimeters.

(a)

(b)

F I G . 2 . (a) Schematic of the Magic
Plate diode spacing, the origin of the
coordinate system is deﬁned as the bottom
left corner diode of the Magic Plate, (b)
Close up of the diode design (distances in
mm).
parameters be performed with the source placed in the center of a

primary photons were generated for each simulation run, and a total

spherical 400 mm radius water phantom, so as to simulate an

of 10 simulation runs were performed. Results from each run were

unbounded phantom.28 The phantom geometry used in this simula-

averaged and the standard deviation (k = 1) calculated.

tion was a 400 mm radius spherical phantom comprised of liquid

The interaction processes for photons (the photoelectric effect,

water with physical density 0.998 g/cm3. The density of 0.998 g/

Compton scattering and Rayleigh scattering) are modeled using the

cm3 was chosen so as to simulate the density of liquid water at

Geant4 Livermore Low Energy Package. The interactions cross-sec-

22°C as is recommended in TG43-U1.27

tions tabulation was taken from the EPDL97 database.31 In order to

The spectrum of gamma energies emitted from the Ir-192 source
was obtained from the NuDat database.29 The b spectrum was not

improve the efﬁciency of the simulations, the linear track-length kerma
estimator32 was utilized with a photon cutoff energy of 250 eV.

considered in the study since its contribution to the dose delivered

Interactions for electrons (multiple scattering, ionization, and

beyond the stainless steel shell is negligible.24,30 A total of 109

bremsstrahlung) are also modeled using the Geant4 Livermore Low
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Energy Package. Secondary particles with range less than 1 lm are
assumed to deposit the dose locally in the interaction voxel.30
To obtain the dose rate in polar coordinates and calculate the
TG-43 parameters, the dose was scored in spherical sections with
thickness of 0.5 mm (from 0 to 200 mm) and angular resolution of
1° (from 0° to 180°) concentric to the longitudinal axis of the source.
The thickness and resolution of the voxels were chosen so as to
ensure the effects of volume averaging was less than 0.1% for distances greater than 5 mm from the source.33 To calculate the
absorbed dose in each of the spherical sections, the total energy
deposited in each section was obtained and divided by the total
mass of the section.
The Ir-192 source is located at the origin of the calculation volume with its longitudinal axis placed along the y axis of the coordinate system, as shown in Fig. 1. To calculate the radial dose
function, the absorbed dose along the z axis was normalized to the
absorbed dose at 10 mm from the center of the source, before
being divided by the normalized (at z = 10 mm) line source geometry
function, as per eq. (6) of the AAPM TG43-U1 report.27
To calculate the 2D anisotropy function, for a given radial distance from the center of the source (r) the absorbed dose was plotted as a function of the angle from the longitudinal axis (h),

F I G . 3 . Partial axial view of voxelized patient geometry in Geant4
source position simulations. The carbon couch is shown below the
patient geometry outlined in green, the Kapton substrate in blue,
and the diode array in pink.

normalized to h = 90°, and then divided by the normalized (again at
h = 90°) line source geometry function, as shown in Equation 8 of
the AAPM TG43-U1 report.27

coordinates were selected as three consecutive source positions
from four catheters. The catheters were selected such that they

2.D | Source position veriﬁcation simulations

spanned the extent of the prostate (L–R and A–P), to determine if
consecutive source positions along a catheter could be localized by

Once the Flexisource model had been validated through TG-43 sim-

the MP at the maximum and minimum distances expected in a clini-

ulations, the same source was simulated inside a voxelized patient

cal HDR prostate brachytherapy treatment. The step size of the

model, and the dose deposited in each of the diodes in the carbon

source used in the treatment planning system was 3 mm.

couch embedded MP was tallied. The MP was modeled in the source

The same geometrical source model as described in Section 2.A

position veriﬁcation simulations as described in Section 2.B, embed-

was used in the simulations, along with the same gamma spectrum

ded inside a 120-mm thick carbon couch, offset 5 mm from its ante-

and interaction processes described in Section 2.C. To prevent over-

rior surface.

lapping volumes, which causes tracking errors in simulations, a paral-

The patient model was created by converting a DICOM CT study

lel geometry was used to place the source within the patient

set from a prostate HDR brachytherapy treatment into a voxelized

geometrical phantom at the planned dwell positions.38 To calculate

model that can be used in Geant4, as shown in Fig. 3. This was

the absorbed dose in each of the sensitive silicon volumes, the total

achieved by ﬁrst converting the Hounsﬁeld unit (HU) numbers to a

energy deposited in each volume was obtained and divided by the

mass density value using a CT–density curve, and then converting

total mass of the volume. Each source position was simulated with

from mass density to a material using a look up table.34–36 Once

109 primary photons for each simulation run. A total of 20 simula-

imported into the simulation, a geometrical phantom is created,

tion runs were performed for each source position; results from each

within which is an array of voxels containing the materials (and their

run were averaged and the standard deviation (k = 1) was less than

compositions) determined from the HU numbers.36 The compositions

1%.

and the densities of materials used in the simulations were obtained
37

Each of the source localization simulations was then repeated

The voxel size was set to

with each voxel in the patient geometry overridden to the density of

3 9 3 9 3 mm3 in this study, to model an accurate geometrical deﬁ-

water, to compare the source localization accuracy of the MP with

nition of patient-related inhomogeneities and prevent prohibitively

and without the presence of patient-related inhomogeneities.

from the AAPM TG 186 Report.

long simulation times.

To determine the distance of each of the 12 source positions to

A selection of 12 source positions from a HDR prostate

all detectors in the array (ai), a separate group of simulations were

brachytherapy treatment plan created in the Oncentra Brachyther-

ﬁrst performed to determine the dose deposited in a single detector

apy treatment planning system (Elekta Brachytherapy, Veenendaal,

placed at 10 mm from the source (D10), along the z axis (as shown

the Netherlands) were used in the simulations. The source position

in Fig. 1) in a water phantom. A total of 10 simulations of 109
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primary photons were performed for this conﬁguration, and the dose
deposited in the single detector averaged across the 10 simulations.
This average dose was then used to normalize the dose from each
detector in the patient geometry simulations (Di), before converting
the relative dose to radial distance.
ai ¼

Di
D10

(1)

The radial distance from each detector to each source position
can then be determined by converting the relative diode dose to distance via a ﬁt of the TG-43 parameters calculated in Section 2.C.
This approach assumes that the diodes are present within a homogeneous water phantom, when in fact the diode dose was calculated
within the heterogeneous patient voxelized phantom. The source
positions were determined using an iterative procedure (Appendix 2).39,40 Once an initial estimation of the source position is found,
a correction factor is then applied to the response of each of the
MP detectors to take into account the angular dependence of the

F I G . 4 . Comparison of calculated radial dose function with studies
by Granero24 and Taylor & Rogers.41

detectors. The source position is then re-estimated using the above
method but uses the initial estimated source position of the previous
calculation. Finally, the calculated source position is compared to
known source positions obtained from the Oncentra Brachytherapy
treatment planning system.

3. | RESULTS
3.A | TG-43 simulations
The radial dose function and anisotropy function (at a radial distance
of 10 mm) calculated in this study, using an active length of 3.5 mm
for the calculation of GL(r,h), are compared to Granero et al.24 and
Taylor & Rogers41 in Figs. 4 and 5, respectively.
The calculated radial dose function from this study was shown
to agree (discrepancies < 1%) with both the Granero24 and Taylor &
Rogers41 benchmark datasets within the calculated uncertainty
(1.2%) in the radial distance range of 1–200 mm. The 2D anisotropy
was also found to agree with the two benchmark datasets to within
1% across the investigated range, verifying the source model and

F I G . 5 . Comparison of calculated 2D anisotropy function at a
radial distance of 10 mm with studies by Granero24 and Taylor &
Rogers.41

simulation physics were adequate to be used in the study. Larger
discrepancies can be observed at polar angles between 0–15° and

statistical uncertainty and may also contribute to the larger discrep-

165–180° due to the minor variations in source capsule modeling

ancies in calculated anisotropy between the studies.

between the studies. In this study, the non-cable end weld of the
stainless steel shell is modeled as a cylinder of length 0.65 mm and
diameter 0.85 mm, whereas in the studies by Granero et al.24 and

3.B | Source position veriﬁcation simulations

Taylor & Rogers41 the end weld is modeled as a 0.108 mm thick

The average difference between MP predicted and actual source

conical section with a half angle of 23° and the radius of the face

positions was found to be 2.1  0.8 mm (k = 1) when all detectors

being 0.17 mm. This conical section was then attached to a

in the array were used in the localization algorithm. Table 1 summa-

0.49 mm long solid cylindrical section to complete the end weld.

rizes the localization results in three dimensions, along with the cal-

This minor difference in the end weld modeling was not observed to

culated three-dimensional difference vector, for different number of

have a signiﬁcant effect on the calculated anisotropy. There is also a

detectors used in the source localization algorithm. When not all

substantial decrease in magnitude of the dose scored in the voxels

detectors in the array were used in the source position veriﬁcation

close to the ends of the source encapsulation due to the signiﬁcant

algorithm, the detectors with the highest deposited dose were cho-

attenuation through the end welds, this leads to an increased

sen. As can be seen from Table 1, the MP could localize the source
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T A B L E 1 Difference between MP predicted and actual source
positions in mm (k = 1).
Number
of
detectors
used

ET AL.

The source position veriﬁcation simulations were then repeated
using the exact same methods, but with each voxel in the patient
geometry assigned a density of water [Figs. 6(a)–6(d)]. The heterogeneous and water only results were compared by means of a Stu-

9

25

49

81

121

dent’s t test (P < 0.05) in each of the X, Y, and Z directions. Only
the Z direction differences were found to be statistically signiﬁcant

X

0.5  1.0

0.2  0.4

0.0  0.2

0.0  0.2

0.2  0.2

Y

0.5  1.1

0.0  0.5

0.0  0.3

0.2  0.3

0.5  0.5

Z

1.8  0.5

1.8  0.5

1.9  0.5

2.0  0.5

2.0  0.5

analysis (P < 0.05) to determine if there was a statistically signiﬁcant

3D

2.4  1.0

1.9  0.5

1.9  0.5

2.0  0.5

2.1  0.6

difference in the localization accuracy depending on the number of

(P < 0.001).
The heterogeneous results were used for a one-way ANOVA42

detectors used. The only signiﬁcant difference was found for the
to within 1 mm in the X and Y directions (left/right and superior/inferior directions, respectively). However, it consistently overestimated the distance in the Z direction (anterior/posterior direction),
with an average error of 1.9 mm.

three-dimensional vector (P < 0.001). Subsequent Student’s t tests
were performed to compare the datasets for the three-dimensional
vector. From this, it was found that only the dataset with nine
detectors had statistically signiﬁcant differences to the other groups.

(a)

(b)

(c)

(d)

F I G . 6 . (a) Difference between MP predicted and actual source position for heterogeneous and water only simulations in X direction, (b)
difference in Y direction, (c) difference in Z direction, and (d) 3D difference vector. Coordinate system orientation is shown in Figs. 1 and 2.
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T A B L E 2 Uncertainty analysis for MC simulations used in this study.
Type A
Statistical variation in absorbed dose determination from repeated MC simulation runs

Type B

1%

Variations of the source geometry from one source to another in manufacturing process24

0.5%

Uncertainty in cross-section library data for Ir-19244

0.5%

Effect of volume averaging on absorbed dose calculation in sensitive volumes

45

0.1%

Uncertainty in composition of tissues used during source tracking simulations46a

2%

Total TG-43 simulation uncertainty

1.2%

Total source tracking simulation uncertainty

2.3%

a

Applies to source tracking simulations only.

4 | DISCUSSION

that source position veriﬁcation using EPIDs is restricted by the limited frame rate and readout electronics of the devices and can result

The uncertainties quoted in this study have been evaluated using

in a signiﬁcant number of dwell positions not being captured by the

the combination of both type A and type B uncertainties combined

EPID when performing source position veriﬁcation.18 Source position

27

and AAPM

veriﬁcation using EPIDs also requires large and expensive systems

TG138.43 A summary of the uncertainty budget for both the TG-43

that have limited availability. This study has shown that similar

simulations and the source tracking simulations is presented in

source position veriﬁcation accuracy to EPIDs17–19 may be achieved

Table 2.

with the MP system. Furthermore, the MP system has been shown

in quadrature, as recommended in AAPM TG43-U1

In a water only geometry, the Magic Plate was able to localize

to have a superior timing resolution of less than 1 ms.20 As such,

the source to within 1 mm. The source localization accuracy, how-

the MP delivers a dedicated, inexpensive HDR brachytherapy in vivo

ever, was found to decrease with the introduction of inhomo-

source position veriﬁcation system with superior timing resolution

geneities. This decrease in accuracy of source position localization

that can easily be mass produced and is practical for routine clinical

due to the presence of inhomogeneities was found to be primarily in

use.

the direction perpendicular to the diode array (z direction). This is

The results of this study, along with previously published experi-

due to the source localization algorithm39,40 z direction estimate

mental results,16,40 indicate that the MP will have sufﬁcient sensitiv-

being more sensitive to the changing ratio of primary to secondary

ity to detect errors in the order of 1–2 mm during the delivery of

photons due to the presence inhomogeneities and increased source

HDR prostate brachytherapy treatments when embedded in a car-

to detector distance.

bon ﬁber couch beneath the patient. Such errors may be due to

The distance estimate in the z direction is depends directly on

incorrect catheter connection or incorrect source strength. However,

the absolute dose deposited in the detector array, whereas source

discrepancies less than 1–2 mm in catheter reconstruction, and small

localization in the x and y directions depends only on the relative

movements of catheters in the time between simulation and treat-

difference between the distance estimate for each detector and

ment may not be detectable unless patient-related heterogeneities

therefore is less sensitive to inhomogeneities. Small inhomogeneities,

can be taken into account during source position veriﬁcation. Fur-

however, can affect the x and y estimate if a smaller number of

thermore, one of the most signiﬁcant challenges for clinical imple-

39,40

detectors are used in the localization algorithm.

mentation of source position veriﬁcation using the MP system is the

This indicates that to track the Ir-192 source with the desired

registration of MP and patient coordinate systems. Previous studies

accuracy during HDR prostate brachytherapy treatments a correction

have overcome this challenge by using stereoscopic imaging,17,48

may be required, based on density information obtained from the

and electromagnetic tracking technology.49,50 Overcoming this chal-

patient CT scan performed prior to treatment. This information could

lenge will be a focus in future publications.

37

built

With the move toward real-time prostate brachytherapy treat-

into the localization algorithm to more accurately predict the source

ment planning based on transrectal ultrasound imaging, future stud-

to detector distances.

ies will also aim to examine the effect of the ultrasound probe on

be used, along with a model-based dose calculation algorithm

Moreover, it was found that source localization accuracy can be
improved with an increased number of detectors used in the localiza-

source localization accuracy and attempt to optimize the MP position to minimize the effects of heterogeneities.

tion algorithm. By increasing the number of detectors used in the localization algorithm, a redundancy is built in to reduce the uncertainty
introduced due to small heterogeneous media in the patient geome47

try.

5 | CONCLUSION

The increased number of detectors is also beneﬁcial due to the

relatively isotropic dose proﬁle at large source to detector distances.40

Source localization using the Magic Plate during a HDR prostate

Previous studies have shown that source position veriﬁcation

brachytherapy treatment was examined using MC simulations. In a

using EPIDs is achievable. However, these studies have also shown

homogenous geometry, the Magic Plate was able to localize the
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source to within 1 mm. The effect of tissue inhomogeneities in the
patient geometry on source localization accuracy was also examined
and was found to increase the difference between Magic Plate predicted and known source positions from the brachytherapy treatment planning system to 2.1  0.81 mm (k = 1). However, this
accuracy can be improved using density information obtained from
CT with the MP accurately registered to the patient geometry, making the proposed tool attractive for use as a real-time in vivo QA
device in HDR brachytherapy for prostate cancer.
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The active Ir-192 core is surrounded by a stainless steel shell of
length 4.6 mm, 0.85 mm outer diameter, and inner diameter of
0.67 mm. This results in a shell thickness of 0.09 mm. The composition by weight of the stainless steel shell is modeled as follows: Fe
67.92%, Cr 19%, Ni 10%, Mn 2%, Si 1%, and C 0.08%, and the physical density is 7.999 g/cm3.
The non-cable end weld of the stainless steel shell is modeled as
a cylinder of length 0.65 mm and diameter 0.85 mm. The cable end
weld of the stainless steel shell is modeled as a partial cone of maximum diameter 0.85 mm, minimum diameter of 0.5 mm, and length
0.4 mm.
Finally, the stainless steel cable is modeled as a cylinder of
5 mm length and 0.5 mm diameter, as recommended by Granero
et al.24 The space between the outer stainless steel shell and the
inner Iridium core was modeled as dry air with a physical density of
1.20 mg/cm3.

APPENDIX 2
SOURCE POSITION VERIFICATION
ALGORITHM
Based on the derived distances (ri) of each diode (i) in the array to
the source, as described in Section 2.D, the estimated source position, Ses(a,b,c) can be calculated. The geometrical distance, di,
between Ses and the coordinate of the i-th detector Di(xi,yi,zi) is calculated by
di ða; b; cÞ ¼

qﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ða xi Þ2 þ ðb yi Þ2 þ ðc zi Þ2

(A1)

To determine the true source position, the geometrical distance,
di, is ﬁtted to the derived distance, ri, by adjusting the estimated
source position. Employing a nonlinear least squares ﬁt method to
determine the estimated source position. In least squares ﬁtting, the
estimate of error assessment can be expressed as the sum of
squares of the relative error, Χ2
X2 ða; b; cÞ ¼

Xn di ðan ; bn ; cn ; xi ; yi ; zi Þ
i¼1
ri

ri

2

(A2)

and assumes that the derived distance, ri, is correct. As there is an
uncertainty associated with deriving ri, if the estimated source position were equal to the true source position, then calculating the
square of the sums of the percentage difference of the value di and
ri would result in a minimum value.

APPENDIX 1
DESCRIPTION OF IR-192 FLEXISOURCE
MODEL
The Ir-192 core is modeled as a pure Iridium cylinder of length 3.5 mm
and diameter 0.6 mm; it has a physical density of 22.42 g/cm3.

To determine a source position that gives the minimal value to
the estimate Χ2 a multivariable Newtown’s method approach is
adopted. The Newton’s method is used in this case to determine the
roots of a function by ﬁnding successively better approximations. In
this analysis, it is necessary to determine the minimum values of Χ2
for all three dimensions of the estimated source position, and can be
expressed as
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dX2 ða; b; cÞ dX2 ða; b; cÞ dX2 ða; b; cÞ
¼
¼
¼0
da
db
dc

(A3)

The Newton’s method for the three source coordinates can be

ET AL.

approach can converge rapidly to a minimum when close, as all three
source coordinates are modiﬁed in a single iteration.
The initial guess is determined by the coordinates of the detector
with the highest response, Dmax(xmax,ymax,z = 0), as the source is

expressed for the k-th iteration as

assumed to be closest to this position. The sum of the squares is calak ¼ ak
bk ¼ bk
ck ¼ ck

1
1
1

dak
dbk

1

dck

1

1

culated using the ﬁrst estimation of the source position,
(A4)

S0es ¼ ða0 ; b0 ; c0 Þ ¼ Ses ðxmax ; ymax ; rmax Þ

(A6)

The source position is then re-estimated using the above
where da, db, and dc are the changes made to the source position to

method, but uses the initial estimated source position of the previ-

produce the improved approximation. These changes can be deter-

ous calculation.

mined by solving a set of linear equations, expressed in matrix form
as
2 2
2 2
2 2 3
dX
dX
d X 2 3 2 dX 3
2
dadc
dadb
6 da
7
6 da 7
6 d2 X2 d2 X2 d2 X2 7 da
6
74 5 6 dX 7
7
6 dbda db2 dbdc 7 db ¼ 6
4 db 5
4 2 2
2 2
2 2 5
dc
dX
dX
dX
dX
dcda dcdb dc2
dc

2

(A5)

This process is repeated until all d’s are sufﬁciently small, or until
further estimations of the source coordinates fail to reduce Χ2. This

